Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Melatonin helps reduce aging signs in human eyelid skin.

The guideline provides recommendations for managing alopecia areata effectively.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Synthetic cosmetics can harm health and the environment.

Yellow dots are common in severe alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

High levels of Demodex mites can cause eye and skin problems.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Nivolumab can cause hair loss as a rare side effect.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Two sisters had rare, widespread cysts and complete hair loss, suggesting a genetic link.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Next-generation sequencing greatly improves understanding and treatment of genetic hair disorders.

Trichoscopy is a reliable method for diagnosing hair-pulling disorder.

JAK inhibitors offer new hope for treating severe alopecia areata.

80% scalp hair regrowth is a successful treatment for alopecia areata.